Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

J Duraiswamy, R Turrini, A Minasyan, D Barras… - Cancer cell, 2021 - cell.com
The mechanisms regulating exhaustion of tumor-infiltrating lymphocytes (TIL) and
responsiveness to PD-1 blockade remain partly unknown. In human ovarian cancer, we …

Genetic and molecular changes in ovarian cancer

RL Hollis, C Gourley - Cancer biology & medicine, 2016 - cancerbiomed.org
Epithelial ovarian cancer represents the most lethal gynecological malignancy in the
developed world, and can be divided into five main histological subtypes: high grade …

Inferring tumour purity and stromal and immune cell admixture from expression data

K Yoshihara, M Shahmoradgoli, E Martínez… - Nature …, 2013 - nature.com
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue
and not only perturb the tumour signal in molecular studies but also have an important role …

Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers

OMT Pearce, RM Delaine-Smith, E Maniati, S Nichols… - Cancer discovery, 2018 - AACR
We have profiled, for the first time, an evolving human metastatic microenvironment by
measuring gene expression, matrisome proteomics, cytokine and chemokine levels …

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

S Shen, G Wang, R Zhang, Y Zhao, H Yu, Y Wei… - …, 2019 - thelancet.com
Background Ovarian cancer (OV) is the most lethal gynecological cancer in women. We aim
to develop a generalized, individualized immune prognostic signature that can stratify and …

[HTML][HTML] The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells

Z Hu, M Artibani, A Alsaadi, N Wietek, M Morotti, T Shi… - Cancer cell, 2020 - cell.com
The inter-differentiation between cell states promotes cancer cell survival under stress and
fosters non-genetic heterogeneity (NGH). NGH is, therefore, a surrogate of tumor resilience …

Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples

M Riester, W Wei, L Waldron… - Journal of the …, 2014 - academic.oup.com
Background Ovarian cancer causes more than 15000 deaths per year in the United States.
The survival of patients is quite heterogeneous, and accurate prognostic tools would help …

Separate enrichment analysis of pathways for up-and downregulated genes

G Hong, W Zhang, H Li, X Shen… - Journal of the Royal …, 2014 - royalsocietypublishing.org
Two strategies are often adopted for enrichment analysis of pathways: the analysis of all
differentially expressed (DE) genes together or the analysis of up-and downregulated genes …